THE ANALYSIS OF THE CHANGE IN GHRELIN LEVEL IN PATIENTS WITH DIFFERENT FORMS OF PARKINSON’S DISEASE

Authors:

Abstract:

The aim of our study was to analyze diurnal fluctuations in hunger hormone level in patients with akinetic-rigid and mixed forms of Parkinson’s disease. The clinical studies have confirmed changes in the ghrelin level with a tendency to increase in the evening in patients of the control group and insignificant diurnal fluctuations in the level of ghrelin in patients with Parkinson’s disease with a tendency to decrease. It has been revealed that in patients with mixed form of the disease, the ghrelin level is lower compared to controls. The human circadian system regulates hunger independently of behavioral factors. There is a large endogenous circadian rhythm of hunger, with a peak in biological evening and a minimum in biological morning. However, the neuroendocrine mechanisms by which the circadian system regulates hunger and appetite remain unclear. Ghrelin, a peptide secreted primarily by the stomach, is the only known circulating orexigenic hormone and a key element in a complex energy balance signaling network. The authors insist that further clinical research is needed to determine the relationship between the intake of antiparkinsonian drugs and the ghrelin level, which can significantly improve the clinical course of this disease.

Keywords:

Parkinson’s disease ghrelin circadian rhythms

References:

1. Kaidashev I.P. Rol molekulyarnykh chasov tsirkadnykh ritmov v patogeneze metabolicheskogo sindroma. Endocrinology. 2020; 2: 158–170 [in Russian].
2. Loginova O.A., Orlova E.G., Shirshev S.V. Fiziologicheskie effekty grelina. Vestnik Permskogo gosuderstvennogo universiteta. Biologiya. 2018; 4:443-443-453 [in Russian].
3. Shabanov P.D., Lebedev A.A., Morozov V.I. Rol grelina v kontrole emocionalnogo, issledovatelskogo i dvigatelnogo povedeniya pri eksperimentalnom posttravmaticheskom stressovom rasstroystve. Mediko-biologicheskie i socialno-psikhologicheskie problemy bezopasnosti v chrezvychajnykh situatsiyakh. 2018; 1: 65–74 [in Russian].
4. Bachmann C., Trenkwalder C. Body weight in patients with Parkinson’s disease. Mov. Disord. 2006; 21:1824-1830.
5. Cabral J, Kringelbach ML, Deco G. Functional connectivity dynamically evolves on multiple time-scales over a static structural connectome: Models and mechanisms. Neuroimage. 2017; 160: 84-96.
6. Gong B, Jiao L, Du X, Li Y, Bi M, Jiao Q, Jiang H. Ghrelin promotes midbrain neural stem cells differentiation to dopaminergic neurons through Wnt/β-catenin pathway. J Cell Physiol. 2020; 235(11): 8558-8570.
7. Mao Y, Tokudome T, Kishimoto I. Ghrelin and blood pressure regulation. Curr Hypertens Rep. 2016; 18:15.
8. Mosińska P., Zatorski H., Storr M., Fichna J. Future treatment of constipation-associated disorders: role of relamorelin and other ghrelin receptor agonists. J. Neurogastroenterol. Motil. 2017; 23: 171–179.
9. Palacios N, Gao X, McCullough M, et al. Obesity, diabetes, and risk of Parkinson's disease. Mov Disord. 2011; 26(12): 2253-2259.
10. Scheer F, Morris C, Shea S. The internal circadian clock increases hunger and appetite in the evening independent of food intake and other behaviors. Obesity. 2013; 21: 421–423.
11. Song N, Wang W, Jia F, et al. Assessments of plasma ghrelin levels in the early stages of parkinson's disease. Mov. Disord. 2017; 32(10): 1487-1491.
12. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004; 1(3):62.
13. Van der Mack MA, Dicke HC, Uc EY, et al. Body mass index in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord. 2012; 18: 263-267.
14. Wang L, Murphy NP, Stengel A, et al. Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats. Neurogastroenterol Motil. 2012; 24(5): 235-245.
15. Zhang P, Tian B. Metabolic Syndrome: An Important Risk Factor for Parkinson’s Disease. Oxidative Medicine and Cellular Longevity. 2014; 1-7.

Publication:

«World of Medicine and Biology» Vol. 16 No. 74 (2020) , с. 145-149
УДК 616.858:615.21:612.018

DOI:

https://doi.org/10.26724/2079-8334-2020-4-74-145-149